Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Abbott Laboratories ABT

Full chart Compare
Set alert

Price alert · ABT

All alert types
113.60 USD -1.91 (-1.65%)

At closeNov 6, 2026, 8:53 AM EST

111.60 -2.00 -1.76%

Pre-market · Nov 6, 8:53 AM ET

112.66 Day range 117.07
81.97 52-week range 132.03
YTD
-9.33%
1 year
-8.78%

Financial health

Altman Z-Score

3.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B3 / 5 overall

  • DCF 4
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 2
  • P/E 2
  • P/B 2

Valuation

P/E 33.5×
FY 2016: 40.4×FY 2017: 211×FY 2018: 53.6×FY 2019: 42.0×FY 2020: 43.4×FY 2021: 35.5×FY 2022: 27.9×FY 2023: 33.4×FY 2024: 14.7×FY 2025: 33.5×
FY 2016 5y median 33.4× FY 2025
P/S 4.9×
FY 2016: 2.7×FY 2017: 3.6×FY 2018: 4.2×FY 2019: 4.8×FY 2020: 5.6×FY 2021: 5.8×FY 2022: 4.4×FY 2023: 4.8×FY 2024: 4.7×FY 2025: 4.9×
FY 2016 5y median 4.8× FY 2025
P/B 4.2×
FY 2016: 2.8×FY 2017: 3.2×FY 2018: 4.2×FY 2019: 4.9×FY 2020: 5.9×FY 2021: 7.0×FY 2022: 5.2×FY 2023: 4.9×FY 2024: 4.1×FY 2025: 4.2×
FY 2016 5y median 4.9× FY 2025
P/FCF 29.6×
FY 2016: 27.2×FY 2017: 22.4×FY 2018: 25.9×FY 2019: 34.1×FY 2020: 33.9×FY 2021: 28.9×FY 2022: 24.7×FY 2023: 37.7×FY 2024: 30.8×FY 2025: 29.6×
FY 2016 5y median 29.6× FY 2025
EV/EBITDA 18.9×
FY 2016: 19.5×FY 2017: 19.2×FY 2018: 20.7×FY 2019: 21.3×FY 2020: 23.0×FY 2021: 21.3×FY 2022: 16.9×FY 2023: 18.8×FY 2024: 18.8×FY 2025: 18.9×
FY 2016 5y median 18.8× FY 2025
EV/Sales 5.1×
FY 2016: 2.9×FY 2017: 4.3×FY 2018: 4.7×FY 2019: 5.3×FY 2020: 6.0×FY 2021: 6.0×FY 2022: 4.6×FY 2023: 5.0×FY 2024: 4.9×FY 2025: 5.1×
FY 2016 5y median 5.0× FY 2025
FCF Yield 3.4%
FY 2016: 3.7%FY 2017: 4.5%FY 2018: 3.9%FY 2019: 2.9%FY 2020: 2.9%FY 2021: 3.5%FY 2022: 4.1%FY 2023: 2.7%FY 2024: 3.2%FY 2025: 3.4%
FY 2016 5y median 3.4% FY 2025

Profitability

Gross Margin 55.5%
FY 2016: 53.9%FY 2017: 47.7%FY 2018: 51.7%FY 2019: 52.3%FY 2020: 50.2%FY 2021: 53.9%FY 2022: 51.1%FY 2023: 50.0%FY 2024: 50.8%FY 2025: 55.5%
FY 2016 5y median 51.1% FY 2025
Operating Margin 18.2%
FY 2016: 15.6%FY 2017: 7.2%FY 2018: 12.6%FY 2019: 14.4%FY 2020: 15.3%FY 2021: 21.4%FY 2022: 19.2%FY 2023: 16.0%FY 2024: 16.3%FY 2025: 18.2%
FY 2016 5y median 18.2% FY 2025
Net Margin 14.7%
FY 2016: 6.7%FY 2017: 1.7%FY 2018: 7.7%FY 2019: 11.6%FY 2020: 13.0%FY 2021: 16.4%FY 2022: 15.9%FY 2023: 14.3%FY 2024: 31.9%FY 2025: 14.7%
FY 2016 5y median 15.9% FY 2025
ROE 12.5%
FY 2016: 6.8%FY 2017: 1.5%FY 2018: 7.8%FY 2019: 11.9%FY 2020: 13.7%FY 2021: 19.8%FY 2022: 18.9%FY 2023: 14.8%FY 2024: 28.1%FY 2025: 12.5%
FY 2016 5y median 18.9% FY 2025
ROIC 8.4%
FY 2016: 4.9%FY 2017: 0.5%FY 2018: 5.4%FY 2019: 7.1%FY 2020: 7.8%FY 2021: 12.6%FY 2022: 11.4%FY 2023: 9.1%FY 2024: 9.9%FY 2025: 8.4%
FY 2016 5y median 9.9% FY 2025
ROA 7.5%
FY 2016: 2.5%FY 2017: 0.6%FY 2018: 3.5%FY 2019: 5.4%FY 2020: 6.2%FY 2021: 9.4%FY 2022: 9.3%FY 2023: 7.8%FY 2024: 16.5%FY 2025: 7.5%
FY 2016 5y median 9.3% FY 2025

Growth (YoY)

Revenue 5.7%
FY 2016: 2.2%FY 2017: 31.3%FY 2018: 11.6%FY 2019: 4.3%FY 2020: 8.5%FY 2021: 24.5%FY 2022: 1.3%FY 2023: -8.1%FY 2024: 4.6%FY 2025: 5.7%
FY 2016 FY 2025
Operating Income 17.9%
FY 2016: 10.2%FY 2017: -39.3%FY 2018: 94.9%FY 2019: 19.4%FY 2020: 15.2%FY 2021: 73.9%FY 2022: -9.1%FY 2023: -23.0%FY 2024: 6.1%FY 2025: 17.9%
FY 2016 FY 2025
EPS (diluted) -51.3%
FY 2016: -68.0%FY 2017: -71.3%FY 2018: 396.3%FY 2019: 53.7%FY 2020: 21.4%FY 2021: 57.6%FY 2022: -0.8%FY 2023: -16.4%FY 2024: 133.6%FY 2025: -51.3%
FY 2016 FY 2025
Free Cash Flow 16.4%
FY 2016: 12.2%FY 2017: 113.0%FY 2018: 10.6%FY 2019: -8.3%FY 2020: 27.3%FY 2021: 51.1%FY 2022: -9.8%FY 2023: -35.2%FY 2024: 25.5%FY 2025: 16.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 4.0×FY 2017: 2.3×FY 2018: 1.6×FY 2019: 1.4×FY 2020: 1.7×FY 2021: 1.8×FY 2022: 1.6×FY 2023: 1.6×FY 2024: 1.7×FY 2025: 1.6×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 1.2×
FY 2016: 3.7×FY 2017: 1.9×FY 2018: 1.2×FY 2019: 1.0×FY 2020: 1.3×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
Debt / Equity 0.3×
FY 2016: 1.1×FY 2017: 0.9×FY 2018: 0.6×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 1.1×FY 2017: 3.0×FY 2018: 2.3×FY 2019: 1.9×FY 2020: 1.4×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.8×FY 2024: 0.7×FY 2025: 0.5×
FY 2016 5y median 0.7× FY 2025
Interest Coverage 23.6×
FY 2016: 10.7×FY 2017: 2.2×FY 2018: 5.3×FY 2019: 5.6×FY 2020: 7.5×FY 2021: 22.4×FY 2022: 26.5×FY 2023: 9.2×FY 2024: 11.3×FY 2025: 23.6×
FY 2016 5y median 22.4× FY 2025

Dividends

Dividend Yield 1.9%
FY 2016: 2.7%FY 2017: 1.9%FY 2018: 1.6%FY 2019: 1.5%FY 2020: 1.3%FY 2021: 1.3%FY 2022: 1.7%FY 2023: 1.9%FY 2024: 2.0%FY 2025: 1.9%
FY 2016 5y median 1.9% FY 2025
Payout Ratio 63.1%
FY 2016: 109.9%FY 2017: 387.6%FY 2018: 83.4%FY 2019: 61.6%FY 2020: 57.0%FY 2021: 45.3%FY 2022: 47.7%FY 2023: 62.1%FY 2024: 28.6%FY 2025: 63.1%
FY 2016 5y median 47.7% FY 2025

Annual · latest fiscal year ends 2025-12-31